Back to search

Article

Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: data from the DA-COVID-19 registry

2020-11-30

Abstract excerpt

<h4>Background: </h4> Few and small studies have described the management of immunomodulant/immunosuppressive therapies or phototherapy in atopic dermatitis (AD) patients during coronavirus disease 2019 (COVID-19) pandemic. <h4>Methods:</h4> A national registry, named DA-COVID-19 and involving 35 Italian dermatology units, was established in order to evaluate the impact of COVID-19 pandemic on the management of ad...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b8a8bd47-338f-5951-ada9-37d4b3db2ae1
DOI
10.22541/au.160674522.20049875/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: data from the DA-COVID-19 registryDOI 10.22541/au.160674522.20049875/v1
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: data from the DA-COVID-19 registry Running title: AD management during COVID-19 pandemicSemantic proximity
Association of demographic characteristics, aggravating factors, comorbidities and treatments with atopic dermatitis severitySemantic proximity
Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional studySemantic proximity
Navigating the atopic dermatitis toolbox: Challenging scenarios and shared decision-making.Semantic proximity
Changing dermatology practice in crisis and normalization processes after COVID-19 and potential problems awaiting us: Teledermatology can be a solutionSemantic proximity
Efficacy Trajectory and Hematologic Safety of Oral JAK Inhibitors in Elderly Patients with Moderate-to-Severe Atopic Dermatitis: A Prospective Real-World StudySemantic proximity
Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 PatientsSemantic proximity
Low Rates of Vaccination Among Atopic Dermatitis, Alopecia Areata, Psoriasis, and Psoriatic Arthritis Patients on BiologicsSemantic proximity
The impact of biologic treatment in psoriasis patients on COVID-19 infection: A single-center retrospective studySemantic proximity
Pattern changes of cutaneous dermatoses among Iraqi women preceding and during the COVID-19 pandemicSemantic proximity
Aggravation of Psoriasis Following Covid-19: A Study of 105 PatientsSemantic proximity
The heightened impact of COVID-19 on emotional wellbeing and delays in care in patients with cutaneous T-cell lymphoma: A cross-sectional studySemantic proximity
Select a neighboring publication to make it the new centre.